Trial Profile
Study of sunitinib in metastatic alveolar soft part sarcoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Apr 2017
Price :
$35
*
At a glance
- Drugs Sunitinib (Primary)
- Indications Alveolar soft part sarcoma
- Focus Therapeutic Use
- 03 Apr 2017 New trial record
- 08 Mar 2017 Results published in the Tumori